Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The study of the chemical and biological properties of CeO2 nanoparticles (CNPs) has expanded recently due to its therapeutic potential, and the methods used to synthesize these materials are diverse. Moreover, conflicting reports exist regarding the toxicity of CNPs. To help resolve these discrepancies, we must first determine whether CNPs made by different methods are similar or different in their physicochemical and catalytic properties. In this paper, we have synthesized several forms of CNPs using identical precursors through a wet chemical process but using different oxidizer/reducer; H2O2 (
CNP1
), NH4OH (CNP2), or hexamethylenetetramine (HMT-
CNP1
). Physicochemical properties of these CNPs were extensively studied and found to be different depending on the preparation methods. Unlike
CNP1
and CNP2, HMT-
CNP1
was readily taken into endothelial cells and the aggregation can be visualized using light microscopy. Exposure to HMT-
CNP1
also reduced cell viability at a 10-fold lower concentration than
CNP1
or CNP2. Surprisingly, exposure to HMT-
CNP1
led to substantial decreases in ATP levels. Mechanistic studies revealed that HMT-
CNP1
exhibited substantial ATPase (phosphatase) activity. Though CNP2 also exhibits ATPase activity,
CNP1
lacked ATPase activity. The difference in catalytic (ATPase) activity of different CNPs preparation may be due to differences in their morphology and oxygen extraction energy. These results suggest that the combination of increased uptake and ATPase activity of HMT-
CNP1
may underlie the biomechanism of the toxicity of this preparation of CNPs and may suggest that ATPase activity should be considered when synthesizing CNPs for use in biomedical applications.
ACS
Nano 2013 Jun 25
PMID:Cellular interaction and toxicity depend on physicochemical properties and surface modification of redox-active nanomaterials. 2366 22